Načítá se...

Combination treatment with flavonoid morin and telomerase inhibitor MST-312 reduces cancer stem cell traits by targeting STAT3 and telomerase

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide. The malignant CRC that undergoes metastasis in the advanced stage is usually refractory to existing chemotherapy and shows a poor prognosis. However, to date, efficient targeted-therapy for metastatic CRC is ill-defined...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Oncol
Hlavní autoři: Chung, Seyung S., Oliva, Bryant, Dwabe, Sami, Vadgama, Jaydutt V.
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4922839/
https://ncbi.nlm.nih.gov/pubmed/27279256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3546
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!